Takeda Pharmaceutical Company Limited develops and commercializes a range of pharmaceutical products. Its portfolio includes treatments for various conditions, such as polycythemia vera and narcolepsy type 1, with a focus on addressing chronic diseases. The company operates in multiple therapeutic areas, including oncology, gastroenterology, and neuroscience, serving healthcare providers and patients globally. Takeda conducts research and development to create new therapies and improve existing treatments.
- Website
- www.takeda.com